Ardent Health, Inc. (ARDT) – What Are Analysts Saying About This Stock?

Ardent Health, Inc. (NYSE:ARDT) has received an average rating of “Hold” from the fifteen research firms that are presently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $12.79.

Several equities analysts have recently commented on ARDT shares. The Goldman Sachs Group restated a “neutral” rating and set a $13.00 price target on shares of Ardent Health in a research note on Thursday, August 6th. Zacks Research raised shares of Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Monday, September 7th. Guggenheim raised their price objective on Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Leerink Partners reaffirmed an “outperform” rating and issued a $14.00 price target on shares of Ardent Health in a report on Friday, September 18th. Finally, Weiss Ratings upgraded shares of Ardent Health from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, October 6th.

Hedge Funds Weigh In On Ardent Health

Several large investors have recently made changes to their positions in ARDT. BlackRock Inc. purchased a new stake in shares of Ardent Health in the second quarter valued at approximately $21,415,000. Algert Global LLC raised its stake in shares of Ardent Health by 1,277.3% during the 2nd quarter. Algert Global LLC now owns 597,745 shares of the company’s stock worth $5,882,000 after buying an additional 554,345 shares during the period. Empowered Funds LLC acquired a new position in shares of Ardent Health during the 2nd quarter worth approximately $5,425,000. Bank of America Corp DE purchased a new position in shares of Ardent Health during the 2nd quarter valued at approximately $3,840,000. Finally, Bank of New York Mellon Corp purchased a new position in shares of Ardent Health during the 2nd quarter valued at approximately $2,377,000.

Ardent Health Stock Performance

Ardent Health stock opened at $12.28 on Wednesday. Ardent Health has a 1-year low of $7.71 and a 1-year high of $15.48. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.10 and a quick ratio of 1.99. The firm has a market capitalization of $1.73 billion, a P/E ratio of 22.33, a price-to-earnings-growth ratio of 3.47 and a beta of 0.72. The company’s 50-day moving average is $11.04 and its 200 day moving average is $10.30.

Ardent Health (NYSE:ARDT) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). The business had revenue of $1.62 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Research analysts forecast that Ardent Health will post 0.96 EPS for the current year.

About Ardent Health

Ardent Health is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women’s health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.

The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.

Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024.